NAD+ and the New Generation of Wellness Injectables: Dr. Daniel Gould Featured in Byrdie

Beverly Hills plastic surgeon Dr. Daniel Gould, MD, PhD was recently featured in Byrdie discussing the growing popularity of NAD+ therapy and the new generation of injectable and intravenous wellness treatments gaining attention across beauty and aesthetics.

NAD+, or nicotinamide adenine dinucleotide, is a molecule naturally present in the body that plays an important role in cellular energy production and DNA repair. Levels decline with age, contributing to growing interest in therapies designed to supplement or support NAD+. Once primarily associated with older patients, these treatments are now increasingly being sought by younger adults.

Dr. Gould tells Byrdie that NAD+ therapy was previously most common among patients over 40, but he has seen an increase in younger adults seeking treatment. Many of these patients are dealing with concerns such as fatigue, low energy, or high levels of stress and are drawn to the potential wellness benefits promoted around NAD+ therapy.

Despite its growing visibility, Dr. Gould emphasizes the importance of separating popularity from scientific evidence. NAD+ infusions are not FDA-approved for aesthetic benefits, and any changes to a patient’s appearance would be indirect rather than a predictable outcome of treatment. He remains cautious about the current enthusiasm surrounding NAD+, noting that its long-term role will depend on stronger research and clearer evidence of benefit.

The article also explores the wider category of wellness injectables, including vitamin therapies and peptides. Unlike traditional facial injectables such as fillers and neuromodulators, these treatments are generally intended to support broader wellness or cellular functions rather than directly alter facial structure. Evidence for many of their promoted aesthetic benefits, however, remains limited.

As wellness and aesthetic medicine continue to overlap, Dr. Gould’s perspective reinforces the importance of approaching emerging treatments with scientific scrutiny. New therapies may hold promise, but understanding what has been clinically demonstrated, what remains theoretical, and what has yet to be established is essential before incorporating them into a broader approach to health, skin quality, or aging.

Read the full article in Byrdie:
https://www.byrdie.com/meet-the-new-injectables-11879974